Model innovation in Parkinson's disease drug development: linking Quantitative Systems Pharmacology to the patient voice

被引:0
|
作者
Barrett, J.
Piccoli, B.
Muller, M.
Barrett, K.
Goncharov, D.
Kaddi, C.
Azer, K.
Romero, K.
Stephenson, D.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
287
引用
收藏
页码:S126 / S126
页数:1
相关论文
共 50 条
  • [41] Bittersweet: A neuroendocrine quantitative systems pharmacology model linking environmental stressors to glucose homeostasis
    Cheng, WanYun
    Snow, Samantha J.
    Hazari, Mehdi
    Kodavanti, Urmila P.
    Conolly, Rory
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S118 - S119
  • [42] Enhancing the incorporation of the patient’s voice in drug development and evaluation
    Meghana Chalasani
    Pujita Vaidya
    Theresa Mullin
    Research Involvement and Engagement, 4 (1)
  • [43] Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid
    Lin, Lin
    Hua, Fei
    Salinas, Cristian
    Young, Carissa
    Bussiere, Thierry
    Apgar, Joshua F.
    Burke, John M.
    Muralidharan, Kumar Kandadi
    Rajagovindan, Rajasimhan
    Nestorov, Ivan
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (03): : 362 - 372
  • [44] Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
    Agoram, Balaji M.
    Demin, Oleg
    DRUG DISCOVERY TODAY, 2011, 16 (23-24) : 1031 - 1036
  • [45] Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists
    Ramasubbu, Mathan Kumar
    Paleja, Bhairav
    Srinivasann, Anand
    Maiti, Rituparna
    Kumar, Rukmini
    INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (04) : 268 - 276
  • [46] Role of imaging in drug development for Parkinson's disease
    Brooks, David J.
    FUTURE NEUROLOGY, 2006, 1 (03) : 335 - 342
  • [47] Parkinson's Disease - Challenges in New Drug Development
    Babic, Tomislav
    Mahovic, Darija
    COLLEGIUM ANTROPOLOGICUM, 2008, 32 (04) : 1275 - 1281
  • [48] Development of a Quantitative Systems Pharmacology (QSP) Model of Psoriasis: Overview and Challenges
    Bansal, Loveleena
    Wilde, Tom
    Kang, Grace
    Baillie, Rebecca
    Friedrich, Christina
    Damian, Valeriu
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S103 - S104
  • [49] Learn-confirm in model-informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
    Franssen, Linnea C. C.
    Swat, Maciej J. J.
    Kierzek, Andrzej M. M.
    Rose, Rachel H. H.
    van Der Graaf, Piet H. H.
    Grimm, Hans Peter
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (02): : 139 - 143
  • [50] Development of a quantitative systems pharmacology model of drug-induced renal proximal tubule injury for benchmarking and translation
    Gebremichael, Yeshitila
    Lu, James
    Shankaran, Harish
    Mettetal, Jerome
    Helmlinger, Gabriel
    Hallow, Melissa
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S46 - S47